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O
ral contraceptives (OCs) have
been determined to be a safe,
efficacious, and convenient form
of contraception.1-5 However, hormonal
contraceptive use by women of child-
bearing age has been suggested to place
women at risk for periodontal diseases.6-10
Early small clinical studies of combined
OCs containing high doses of estrogen
(>50 µg of estrogen and ≥1 mg progestin)
found that these drugs increased the risk
for gingival disease and suggested an
adverse effect on the underlying sup-
porting periodontal tissues.11-15 Other
studies report that gingival inflammation
increases in direct relationship with the
duration of combined OC use.16,17
Limited animal studies also have lent
support for these notions, suggesting
that OCs have marked effects on the
gingival microvasculature, altered capil-
lary permeability, and cellular immune
response seen in gingival diseases.18-21
As a result of these studies, the dental
community has often attributed poor gin-
gival health to the use of these steroid
preparations in women who use OCs,
although these data are now over 25 years
old.
Since 1976, formulations of OCs have
changed dramatically, resulting in
brands that contain <50 µg estrogen and
≤1 mg progestin.22-25 A more recent
small clinical study indicated no as-
sociation between low-dose OCs and
gingivitis.26 However, the relationship
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Table 1.
Differences in the NHANES I and 
NHANES III Data Sets
Dental 
Examination NHANES I NHANES III
Periodontal Periodontal Clinical 
measures index (PI) attachment (CAL)
Periodontal probing
Gingivitis PI Bleeding on probing
Calculus OHI-S Calculus index
Teeth examined Full mouth 2 diagonally opposite 
quadrants
Oral health Toothbrushing None
behaviors frequency
OC measures OC use in the last OC use (ever/never)
6 months (Y/N)
Are you still using Are you still using 
them now (Y/N) them now (Y/N)
Age OC initiated 
Duration of OC use
How many months 
ago did you stop 
taking OC
Tobacco Collected only for a Collected for 
exposure subgroup of the all individuals 
25- to 74-year-old >12 years
sample
Time since last Collected only for Collected for 
dental visit a subgroup of the all individuals 
25- to 74-year-old >12 years
sample
between OCs and periodontal diseases using a large,
population-based representative sample has not been
investigated.
The current study expands on previous investiga-
tions conducted by using a subset of the sample of
the U.S. population participating in the first and third
National Health and Nutrition Examination Surveys
(NHANES I and NHANES III). The purpose of this study
was to evaluate the historically suggested association
between “high-dose” OC use and periodontal diseases
and to determine whether an association exists among
users of the currently available “low-dose” OCs and
periodontal conditions in females aged 17 to 50 years
in the U.S. population.
MATERIALS AND METHODS
Data Source
Data for this study were obtained from NHANES I,
conducted between 1971 and 1974 and NHANES III,
conducted between 1988 and 1994.27,28 The NHANES
surveys are cross-sectional studies designed to obtain
information on the health and nutritional status of the
non-institutionalized population of the United States
conducted by the National Center for Health Statistics
(NCHS). The sampling plan of each of the surveys fol-
lowed a highly stratified multistage probability design
in which a sample of the U.S. civilian, non-institution-
alized population was selected to provide national esti-
mates. Methods for the standardized interviews, dental
examinations, and procedures for human protection
and consent have been described elsewhere.29,30 While
overall the surveys are meant to be similar, some dif-
ferences between surveys are shown in Table 1. The
differences in the method of measuring periodontal
conditions between the surveys did not allow for direct
comparison. Furthermore, the number of records avail-
able for analysis varied depending on the variables
used.
We limited the analyses to 4,930 (NHANES I) and
5,001 (NHANES III) non-pregnant, premenopausal
women ages 17 to 50 years. A lower age boundary
of 17 years was used to ensure that all individuals
were eligible for data collection on contraception prac-
tices and the upper age boundary of 50 years to avoid
issues related to misclassification effects due to
postmenopausal hormonal therapy. Data were
excluded for women who were pregnant, post-
menopausal, or indicated the use of non-oral forms
of contraception. In NHANES III, women reporting
the use of a brand of OC that contained >50 µg of
estrogen were excluded from the NHANES III analysis
(N = 4). Menopausal status was ascertained based on
a respondent’s report that her menstrual periods had
not occurred within the last 12 months or stopped
entirely (excluding women who were reported to be
breastfeeding or pregnant).
Clinical Examinations
All dental examinations were conducted by trained and
standardized examiners in dental units located in mobile
examination centers (MEC). The periodontal status of
individuals in NHANES I was assessed using the perio-
dontal index (PI).31 The PI, a visual numeric index,
assessed the degree of inflammation and the suspected
presence of periodontal pockets around all teeth pre-
sent in the mouth including third molars where zero
indicated no disease, 1 = mild gingivitis, 2 = severe gin-
givitis, 6 = gingivitis with suspected pocket formation,
and 8 = advanced periodontal bone loss and loss of
function. The presence of calculus was measured on six
teeth using the simplified oral hygiene Index (OHI-S).
NHANES III periodontal measures were conducted on
randomly assigned half-mouths (one upper and one
diagonally opposite lower quadrant) for each individual,
excluding third molars. A periodontal probe was used
to measure clinical attachment loss (CAL), probing
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depth (PD), gingival bleeding, and calculus on the buc-
cal and mesial-buccal aspect of each tooth.30
OC Use (Exposure to Sex Steroids)
As noted in Table 1, OC use was assessed differently
in the two NHANES surveys. Oral contraceptive use
was assessed from the two interview questions in
NHANES I “Have you taken birth control pills in the
last 6 months?” and “Are you still taking them now?”
Three categories for OC use were derived from these
questions: current use, use within last 6 months, and
non-current use. In NHANES III, OC use was derived
from the two interview questions “Have you ever taken
birth control pills for any reason?” and “How many
months ago did you stop taking birth control pills or
are you still taking them?”
In order to establish a definition of exposure (OC
use) that could be compared between the two surveys,
it was necessary to recode OC exposure in the
NHANES III survey. This was achieved by creating the
same categories of current use, use within the last
6 months, and non-current use to match the way the
data were collected in the NHANES I. In both surveys,
to attain the greatest contrast between the groups, any
woman who had reported OC use in the last 6 months
but was not currently using on the day of the NHANES
examination was excluded from the analysis.
Measurement of Periodontal Conditions
Gingivitis. In NHANES I, gingivitis was defined as the
presence of at least one tooth with a PI score of 1 or
greater in the mouth. For NHANES III, the presence or
absence of bleeding on probing at one or more sites
was used to define gingivitis.
Periodontitis. The case definition for moderate perio-
dontitis in NHANES I was defined as an individual with
at least three teeth with a PI sore of 6 (gingivitis with
pocket formation) or disease with pockets.32,33 For
NHANES III, moderate periodontitis was defined as at
least two sites with 4 mm of clinical attachment loss
and a probing depth ≥4 mm.
Sociodemographic Covariates
Sociodemographic, life indicators, and behavioral fac-
tors which have been shown to be associated with OC
use were evaluated for confounding and effect modifi-
cation. Variables obtained from the face-to-face inter-
view included age, which was specified as both
continuous and categorical, with three age categories
(17 to 27 years, 28 to 37 years, and 38 to 50 years)
in both surveys. Race was defined as black or white in
both surveys. Hispanic ethnicity was not recorded in
NHANES I and, therefore, could not be included in these
analysis. Marital status was defined as married (married
or living together as married), never married, or other.
Education level was reported as <12 years of education,
12 years of education, or >12 years of education.
Poverty income ratio is the ratio of reported family
income category divided by the poverty income thresh-
old. Using the recommended cutpoints for improved
precision from the NHANES III Analytic Guidelines,34
three categories, low, medium, and high, were created
for poverty index level in both data sets – 0.00 to 1.350,
1.351 to 3.500, and >3.501. Parity was collected from
the question “How many live births have you had?”
Parity was coded as a categorical variable with cate-
gories being 0, 1 to 2, >3 live births. Smoking status
was defined as never smoked (<100 cigarettes in life-
time), former smoker (a positive answer to ever smoked
but do not smoke cigarettes now), and current smoker
(a positive answer to smoke now and have smoked
≥100 cigarettes in a lifetime). Information on alcohol
use and last dental visit was obtained by interview.
Statistical Analysis
The NHANES I and NHANES III surveys involve com-
plex sampling designs; therefore, all statistical anal-
yses were performed taking into account the effect
of the study design as well as incorporating the
examination sampling weights. The dependent vari-
ables of gingival inflammation and periodontitis were
dichotomized and reported as present or absent. Initially,
univariate statistics were calculated for all variables to
describe the variables and their distributions along with
measures of crude association (prevalence odds ratios
[OR]) between the outcomes (periodontitis, gingivitis)
and other covariates of interest for the total sample in
each survey. Measures of association were calculated
using the chi square test of association. Tests of trend
were performed using ordinary logistic regression and
assigning ordinal scores for categories of age for both
univariate and stratified analysis to investigate any
trends in prevalence by age within OC groups in each
survey. Potential confounding or effect modifying rela-
tionships between the covariates and the major out-
comes were assessed using stratification and the
comparison of the log-likelihood ratios of multivariable
models with and without the interaction terms. Multi-
variable logistic regression analysis was conducted to
assess the independent effect of OC use while con-
trolling for all other covariates in each survey.
All analyses were conducted using a software pack-
age‡ which can account for complex sampling design
and which gives adjusted variance estimations. There-
fore, in all tables the number of participants per cat-
egory is unweighted, while all means, percentages,
and ORs are weighted to reflect the target population
and standard errors and 95% confidence intervals (CI)
are adjusted for sampling design.
‡ STATA Statistics and Data Analysis, Version 6, STATA Corporation,
College Station, TX.
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RESULTS
There were 4,930 (NHANES I) and 5,001 (NHANES III)
non-pregnant, premenopausal women aged 17 to 50
years with both interview and examination data avail-
able for analysis. Of these, 4,662 in NHANES I and
4,648 in NHANES III had at least six teeth and com-
plete periodontal assessments. However, only 4,665
(NHANES I) and 4,510 (NHANES III) had complete
data on OC use. The proportion of women who cur-
rently used OCs at the time of NHANES I (22.1%) was
slightly higher than at the time of NHANES III (20.0%)
(Table 2). This represented approximately 10,057,478
and 843,963, respectively, of the total number of
women of child-bearing age in the United States at the
time of each survey.
Both surveys showed that women who chose to use
OCs were more likely to be younger than 33 years of
age, white, non-smokers; less likely to have diabetes;
more likely to have higher levels of education and
income; have higher perceptions of their own oral
health; and were more likely to participate in lifestyle
behaviors such as moderate alcohol consumption and
Table 2.
Selected Characteristics of NHANES I and NHANES III Non-Pregnant, Premenopausal
U.S. Women Aged 17 to 50 Years With and Without Periodontal Examinations
NHANES I (N = 4,930) NHANES III (N = 5,001)‡
With Exam Without Exam With Exam Without Exam
Characteristic N* %† N* %† P Value N* %† N* %† P Value
Age (years; SE) 4,662 30.0 (0.22) 268 39.2 (0.45) 0.01 4,648 32.0 (0.12) 240 34.9 (0.62) 0.01
OC use
Current 1,106 22.1 42 15.7 842 20.4 20 6.1
Past 252 5.3 13 3.8 2,488 58.4 195 66.6
Never 3,307 72.6 204 80.5 0.01 1,180 21.5 91 27.2 0.01
Race
White 3,709 87.5 217 92.2 2,832 81.2 150 78.4
Black 892 11.3 38 7.3 0.07 1,630 13.8 83 12.8 0.26
Marital Status
Married 3,086 65.6 201 81.3 2,502 59.6 116 60.6
Single 1,059 25.1 15 5.2 1,462 26.8 72 21.9
Other 524 9.3 42 13.3 0.01 676 13.6 51 17.6 0.08
Education
<12 years 1,251 22.6 130 43.2 1,468 19.0 106 28.3
12 years 2,008 46.0 107 48.2 1,676 35.6 85 45.4
>12 years 1,368 31.4 21 8.6 0.01 1,481 45.4 48 26.3 0.01
Income Level
Low 1,210 21.0 75 20.7 1,678 22.2 95 27.9
Middle 1,919 50.3 125 43.3 1,457 34.3 72 49.2
High 1,382 28.7 54 36.0 0.05 1,125 43.5 41 22.9 0.01
Smoking
Current 260 36.3 35 59.1 1,089 27.9 91 43.5
Past 97 13.5 8 14.8 515 14.3 31 14.8
Never 360 50.2 18 26.1 0.01 3,044 57.7 118 41.6 0.01
Parity
0 1,260 31.2 20 8.9 1,325 35.0 40 23.4
1-2 890 18.2 33 12.4 1,981 45.6 79 39.2
≥3 2,513 50.7 209 78.8 0.01 1,228 19.4 80 37.4 0.01
* The differences in the total number for each examination category and the subtotals for each of the variables are due to missing data or data intentionally
collected due to study design.
† Weighted percentage.
‡ Women were excluded who had partial periodontal examinations, N = 113.
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utilizing dental care more frequently (unpublished
data). The potential bias introduced by non-participa-
tion in the dental examinations in both surveys is
shown in Table 2. In both NHANES I and NHANES III
there were some statistically significant differences
among women with periodontal examinations and
those without periodontal examinations. The women
with periodontal examinations were significantly
younger and more likely to use OCs, have higher 
levels of education, to be non-smokers, and have
children compared to women without periodontal
examinations.
Periodontal Characteristics
Table 3 presents the periodontal conditions for pre-
menopausal adult U.S. women, 17 to 50 years of age,
stratified by OC use. Gingivitis and calculus were
common among women in both surveys. The mean
age was 30.0 (SE 0.22) years in NHANES 1 and
32.0 (SE 0.12) years in NHANES III. The mean num-
ber of teeth present was slightly higher in NHANES
III (26.5; SE 0.09) than in NHANES I (25.4; SE 0.11).
Using the case definition in this study, the overall
prevalence of moderate periodontitis in the NHANES
I population was 13.1% and 10.7% in the NHANES
III population.
When comparing women by history of OC use,
women who reported current use were significantly
younger (P <0.01) than women who reported non-cur-
rent use in both surveys. No significant differences
were found in the prevalence of gingivitis or calculus
between current or non-current users in both surveys
(Table 3). Current OC users had a significantly lower
prevalence of periodontitis than non-current users
(8.9% versus 13.3%, P <0.01) and (4.4% versus 12.5%,
P <0.01) as well as less tooth loss in both surveys.
Moreover, current OC users in NHANES III had a lower
mean CAL as well as lower mean probing depth than
non-current users.
Prevalence of Periodontal Conditions
There were no significant differences in the prevalence
of gingivitis between current OC users and non-current
users after stratifying for individual risk indicators such
as age, marital status, race, educational level, income
level, smoking status, number of births, time since last
dental cleaning, self-perception of oral and general
health, presence of insurance, and alcohol use for either
NHANES surveys (data not shown).
Table 4 shows the prevalence of moderate perio-
dontitis within selected demographic variables strati-
fied by OC use. Overall, current OC users showed a
Table 3.
Periodontal Characteristics of Non-Pregnant, Pre-Menopausal U.S. Women Aged 17 to
50 Years by OC Exposure
NHANES I, 1971-74 (N = 4,413)* NHANES III, 1988-1994 (N = 4,169)*
Current Non-Current Current Non-Current
Users Users Total Users Users
Characteristic N %§ (SE)‡ N %§ (SE)‡ P Value† N %§ (SE)‡ N %§ (SE)‡ N %§ (SE)‡ P Value† N %§ (SE)‡
Periodontal 1,106 3,307 4,413 842 3,327 4,169
assessment
Mean age 27.1 (0.30) 31.1 (0.24) 0.01 30.0 (0.22) 25.8 (0.18) 34.1 (0.15) 0.01 32.0 (0.12)
Gingivitis 36.0 38.4 0.26 37.8 47.7 48.1 0.88 47.9
Calculus 38.9 41.7 0.22 40.7 41.1 47.2 0.09 45.9
Periodontitis 8.9 13.3 0.01 13.1 4.4 12.5 0.01 10.7
% PD ≥4 mm – – – – 10.8 17.0 0.01 16.0
Mean PD – – – – 1.3 (0.03) 1.7 (0.02) 0.03¶ 1.5 (0.03)
Mean CAL – – – – 0.45 (0.03) 0.73 (0.02) 0.00¶ 0.66 (0.03)
Mean N teeth 26.3 (0.17) 25.0 (0.13) 0.01 25.4 (0.11) 27.0 (0.06) 26.3 (0.07) 0.01 26.5 (0.09)
* Excludes women who had indicated OC use within the last 6 months but who were not currently using on the day of the examination.
† Comparisons were carried out using a chi square test.
‡ Standard error of the mean.
§ Weighted percentage.
 Data not collected for NHANES I survey.
¶ Comparisons were carried out using a two-sample t test.
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Table 4.
Prevalence of Periodontitis for Selected Covariates Stratified by OC Use Among 
Non-Pregnant, Premenopausal U.S. Women Aged 17 to 50 Years: NHANES I and III
Current Non-Current Current Non-Current 
Users Users Users Users 
(N = 1,106) (N = 3,307) (N = 842) (N = 3,327)
Prevalence Prevalence Prevalence Prevalence
Covariate Total N N %† N %† P Value* Total N N %† N %† P Value*
Overall prevalence 8.9 13.1 0.02 4.4 12.5 0.01
Age (years)
17-27 1,641 583 5.4 1,058 3.9 1,521 559 2.6 962 3.7
28-37 1,739 424 6.4 1,315 11.0 1,430 256 11.3 1,174 13.2
38-50 1,033 99 14.3 934 19.1 0.01‡ 1,218 27 5.3 1,191 22.1 0.01‡
Race
White 3,507 891 6.1 2,613 9.7 2,548 551 4.0 1,997 11.4
Black 911 215 10.8 694 19.3 0.01 1,620 291 6.8 1,329 17.1 0.01
Marital Status
Married 2,893 788 6.0 2,105 12.3 2,273 418 4.9 1,855 13.2
Single 1,019 198 3.4 821 4.2 1,276 340 1.9 936 5.4
Other 499 120 14.6 379 24.7 0.01 612 84 12.3 528 20.9 0.01
Education
<12 years 1,191 225 13.4 963 19.8 1,324 219 10.7 1,105 17.4
12 years 1,958 510 5.8 1,446 10.0 1,497 312 4.5 1,185 16.3
>12 years 1,244 368 4.5 876 5.0 0.02 1,327 307 2.6 1,020 7.4 0.08
Poverty index level
0-1.35 1,116 255 11.6 859 15.6 762 174 10.5 588 16.9
1.351-3.500 2,165 549 8.5 1,613 11.7 1,624 320 5.0 1,304 13.3
≥3.501 990 265 2.5 725 7.3 0.01 1,455 283 1.7 1,172 9.6 0.01
Smoking status§
Current 243 53 21.5 190 25.9 978 175 8.0 803 21.5
Past 94 17 0.0 77 12.6 470 84 3.6 386 11.9
Never 343 58 5.2 284 14.8 0.01 2,721 583 3.2 2,138 8.2 0.01
Last dental visit§
≤2 years ago 408 95 7.5 313 10.4 1,956 434 2.8 1,522 8.5
>2 years ago 149 19 15.8 138 28.2 0.01 2,059 374 7.3 1,685 18.4 0.01
Alcohol use
Yes 3,412 938 6.6 2,480 9.9 3,093 637 4.0 2,456 12.6
No 9,95 168 7.4 827 13.9 0.01 1,074 205 7.0 869 12.3 0.01
Parity
0 1,214 295 3.0 909 4.1 1,200 342 1.1 858 5.4
1-2 820 287 4.6 523 11.1 1,793 400 8.4 1,393 13.1
≥3 2,389 524 10.3 1,864 15.0 0.00‡ 1,174 100 14.7 1,074 20.1 0.00‡
* P values for Cochran-Mantel-Haenszel chi-square test of association between OC groups.
† Weighted percentage.
‡ Tests of trend were performed using ordinary logistic regression and assigning ordinal scores for categories of age and parity; significance set at P <0.05.
§ The variables smoking status and time since last dental visit were collected for only a subgroup of individuals in the NHANES I survey.
 Small number of observations in cell.
consistent pattern of having a lower prevalence of
periodontitis compared to non-current users. The preva-
lence of periodontitis increased with age, with non-
current users demonstrating greater incremental
increases in prevalence in each succeeding age group.
Overall, the prevalence of periodontitis exhibited
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significantly increasing trends across age groups,
younger to older. Despite a large number of current
OC users having missing data for smoking exposure in
NHANES I, due to this variable being collected only
for a subgroup of the sample, we still observed the
expected association of an increased prevalence of
periodontitis among current smokers compared to
never smokers in both groups. The fact that current
OC users in NHANES III were, on average, 8 years
younger than women who were classified non-current
users may account for the consistent pattern of lower
prevalence of moderate periodontal disease among cur-
rent users.
We assessed the possibility that the relation between
OC use and prevalence of periodontitis was modified
by age or smoking. In NHANES I, there was a mar-
ginally significant interaction between current OC use
and periodontitis in the middle age group of women (28
to 37 years) who were current OC users (P = 0.043).
Although there was a consistent pattern of reduced
prevalence of periodontitis among current OC users
compared to non-current users in NHANES III, it
appeared that there was a greatly reduced risk of perio-
dontitis among the oldest age group of current OC
users. The results of the stratified analysis were not
significant and it was determined that this apparent
reduced risk was the result of the small number of
users among the oldest age group, rather than hetero-
geneity within the groups. Interactions between
smoking status and OC use were not statistically sig-
nificant in either NHANES survey, but the NHANES I
analyses had low power to detect interactions due to
the small number of subjects for whom smoking data
were collected.
Multiple Regression Modeling
Separate multiple variable logistic regression
models were fit to examine the association
of OC use and periodontal conditions of
women using high-dose OCs compared to
women not using OCs (NHANES I) and
women using low-dose OCs compared to
women not using OCs (NHANES III). All
models were adjusted for age, race, educa-
tion level, poverty index level, marital sta-
tus, alcohol consumption, presence of
calculus, and parity. Smoking status and time
since last dental visit data were not collected
for the entire sample in the NHANES I sur-
vey. Therefore, only NHANES III models were
adjusted for these variables. Variables were
retained in the final models if they were sta-
tistically significant at the 0.05 level or if their
removal caused a 5% or more change in the
odds ratio for the periodontal condition of
interest.
NHANES I (High-Dose OC)
Gingivitis model. Unadjusted for confounding variables,
current OC use was associated with a 24% lower preva-
lence of gingivitis when compared with non-current
OC use among premenopausal women ages 17 to 50
years (OR = 0.76; 95% CI: 0.42 to 0.98) (Table 5).
After adjustment for confounding variables and sam-
pling design, current OC use still suggested a protec-
tive association (OR = 0.65; 95% CI: 0.42 to 1.01),
although this association did not reach statistical sig-
nificance. Factors that remained significantly associa-
ted with the prevalence of gingivitis (data not shown)
were older age, lower levels of education (not having
graduated from high school), lower poverty index level,
presence of dental calculus, and higher parity.
Periodontitis model. There was a significant pro-
tective association between current OC use and mode-
rate periodontitis (OR = 0.58; 95% CI: 0.45 to 0.77) in
the unadjusted analysis (Table 5). When the data were
further adjusted for all significant factors from the
bivariate analysis, OC use was associated with slightly
decreased odds of periodontitis (OR = 0.36; 95% CI:
0.13 to 0.96). Increased age, being previously married,
lower poverty index level, having less than a high
school education, and presence of dental calculus were
variables associated with increased odds of periodon-
titis (data not shown).
NHANES III (Low-Dose OC)
Gingivitis model. Similar to NHANES I, the crude or
unadjusted odds ratio showed a protective association
between gingivitis and current OC use when compared
with non-current use (OR = 0.82; 95% CI: 0.68 to
0.97). Current OC use was associated with a slightly,
Table 5.
Final Logistic Regression Models of the Association
Between Oral Contraceptive Use and Periodontal
Diseases, Controlling for Selected Variables, Among
Premenopausal Women Aged 17 to 50 Years
NHANES I N = 4,413 NHANES III N = 4,169
Periodontal Crude Adjusted Crude Adjusted 
Status OR (CI) OR (CI) OR (CI) OR (CI)
Gingivitis OR = 0.76 OR = 0.65* OR = 0.82 OR = 0.80†
(0.42-0.98) (0.42-1.01) (0.68-0.97) (0.61-1.02)
Periodontitis OR = 0.58 OR = 0.36‡ OR = 0.32 OR = 0.73§
(0.45-0.77) (0.13-0.96) (0.23-0.45) (0.50-1.07)
* Model adjusted for OC use, age, race, marital status, poverty index level, education level,
presence of calculus, alcohol use, and parity.
† Model adjusted for OC use, age, race, marital status, poverty index level, education level,
presence of calculus, alcohol use, and smoking status.
‡ Model adjusted for OC use, age, marital status, poverty index level, education level,
presence of calculus, alcohol use, and parity.
§ Model adjusted for OC use, age, marital status, race, poverty index level, education level,
presence of calculus, smoking status, alcohol use, and time since last dental visit.
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but not statistically significant, lower prevalence of gin-
givitis (OR = 0.80; 95% CI: 0.61 to 1.02) when adjusted
for similar covariates (data not shown) as in the
NHANES I gingivitis model (Table 5). However, unlike
the NHANES I model, increasing age in NHANES III
significantly decreased the odds of having gingivitis.
Also, current smokers showed a significantly decreased
likelihood of having gingivitis compared to never
smokers.
Periodontitis model. The crude model estimated a
significant association between current use of OCs and
decreased probability of having periodontitis (OR =
0.32; 95% CI: 0.23 to 0.77). Adjustment with the
covariates in the final model virtually eliminated the
apparent protective effect of OC seen with the crude
OR model (OR = 0.73; 95% CI: 0.50 to 1.07) (Table 5).
Of the covariables in the model (data not shown),
increasing age, being non-white, current smoker,
presence of calculus, having a high school or less
education, and being among the lowest poverty index
level significantly increased the probability of having
periodontitis.
DISCUSSION
The controversy over the safety of OCs has been the
topic of much debate. The suspicion that high-dose
OCs were associated with an increased risk of throm-
botic events prompted a dramatic decrease in estro-
gen content from >100 µg of ethinyl estradiol to 20
to 50 µg in current formulations soon after these
preparations were introduced onto the market.35
Moreover, the debate on the effects of OC use and
periodontal diseases has drawn heavily from studies
that report an increase in gingival inflammation
related to hormone changes during pregnancy36-39
as well as small clinical studies evaluating high-dose
OCs.11-13 Today, for most healthy women, OC use is
considered to be a safe, convenient, and effective
method of contraception. Yet, current thinking still
suggests that low-dose OC use potentiates gingival
or periodontal diseases as reflected in the recent
consensus report related to periodontal diagnosis from
a workshop held in 1999 by the American Academy
of Periodontology recommending the classification
of “OC induced gingivitis,”40 despite the fact that
these data came from small trials which are over
25 years old.
The aim of this study was to examine the relation-
ship between OC use and gingivitis and periodontitis
in premenopausal women, using large population-
based representative samples. It was anticipated that
the OC users in NHANES I would have a higher preva-
lence of gingival inflammation and poorer periodontal
health than non-OC users resulting from the higher
doses of estrogen and progestins of the high-dose
(>50 µg estrogen) OC pills of the early 1970s. In addi-
tion, we anticipated that women using the modern
low-dose OC pills available at the time of NHANES III
would exhibit an increased, yet less marked, preva-
lence of gingivitis and periodontitis than those not
using OCs.
In NHANES I, a negative association (protective)
between current OC use and gingivitis was suggested
after controlling for all potential confounding vari-
ables including age, but failed to reach the signifi-
cance level of P <0.05 (P = 0.057). These results were
unexpected based on earlier reports that demon-
strated an increase in gingival inflammation among
users of OC.12-14
Using the gingival index (GI) to assess gingival
inflammation, El-Ashiry et al.12 reported significantly
increased gingival inflammation among young women
who had used sex steroid contraceptives when com-
pared to women of similar ages who had not used OC.
Another cross-sectional study conducted by Kalkwarf13
demonstrated that the women using OCs had more
gingivitis independent of dental plaque scores; however,
this study has been criticized for the study design and
sample size deficiencies.6 In addition, studies that used
the GI to measure gingivitis indicated that gingival
inflammation increases in direct relationship with the
duration of OC use.16,17
Direct comparisons of our study with these previous
studies examining the relationship of gingival conditions
and OC use are difficult, as different methods were
used to measure disease. The earlier studies used the
GI to assess gingival inflammation, while the PI was
used in NHANES I. The GI combines both a visual and
a periodontal probe assessment to measure the severity
of the gingival lesion, whereas the PI employs only a
visual assessment. The PI has been criticized as being
subjective and less accurate than the GI since it does
not take into account the clinical distinction between
health and various levels of severity.41 As such, the
difference in our results may be related to use of dif-
ferent measurement methods.
According to our results, modern low-dose OC use
did not increase the prevalence of gingivitis. As in
NHANES I, OC use was not associated with increased
prevalence of gingivitis. Interestingly, again, a non-
significant protective association was seen. In addition,
when comparing the multivariable models, the mag-
nitude of the effect of OC use on gingivitis between the
NHANES I and III surveys was roughly equal.
A review of a recent clinical study investigating
low-dose OCs lends support to our findings.42 Pre-
shaw and colleagues demonstrated, using a prospec-
tive, split-mouth, experimental gingivitis model in 30
premenopausal women, that low-dose OC formula-
tions failed to intensify gingival disease after evalu-
ating mean plaque index, gingival index, or gingival
crevicular fluid volumes. These findings, in keeping
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with ours, resulted in the authors concluding that low-
dose OC formulations do not influence the inflam-
matory response of the gingival tissues to dental
plaque.42 Conversely, in a clinical study by Tilakaratne
et al.,43 which examined the effect of OCs and
injectable progestin-only contraceptives on perio-
dontal conditions, found that women who used hor-
monal contraceptives for <2 years showed higher
mean GI scores than non-users. However, the
Tilakaratne et al. study did not differentiate between
participants using OCs or injectable progestin-only
hormones. As Preshaw and colleagues point out,42
this is of potential importance because the daily dose
of progestin from the progestin-only injectable method
is estimated to be 10 times higher than the dose of
progestin found in the OC formulation used in the
Tilakaratne et al. study.
In both NHANES I and NHANES III a relatively
strong protective association was seen between perio-
dontitis and current OC use, using univariate analysis
(OR = 0.58; 95% CI: 0.45 to 0.77) and (OR = 0.32;
95% CI: 0.23 to 0.45), respectively. However, no sta-
tistically significant relationship was seen in the
NHANES I analysis after adjusting for potential
confounders. The lack of an association between OC
use and periodontitis shown in our analysis supports
a previous study by Pankhurst et al.16 which detected
no change in the periodontal attachment levels in
women taking oral contraceptives compared to con-
trols. In contrast, Knight and Wade reported a signifi-
cant loss of attachment in women using oral
contraceptives for over 18 months, although there were
no differences in gingival inflammation between OC
users and non-users.17 Possible explanations for the
inconsistency between our findings and the Knight and
Wade study are differences in measurement of perio-
dontal disease, sample sizes, selection bias, or greater
examiner variation. Furthermore, our analysis evalu-
ates current OC use and does not differentiate by dura-
tion of use.
A possible reason for the absence of a significant
finding in our analysis for modern low-dose oral con-
traceptives may lie in the way OC exposure was
defined for the analysis of the NHANES III data. As
mentioned before, the exposure questions were differ-
ent in each survey. Our recategorization of OC use in
NHANES III resulted in approximately 2,148 women
who had a history of past exposure to OCs (some of
whom had up to 20 years of exposure) being placed
into the “non-current use” group. In an effort to make
the OC data comparable between the surveys, there
may have been some misclassification of the out-
comes, resulting in the dilution of the association
between OC use and periodontal disease.
To determine if the recategorization of OC use
affected the outcome, subsequent analysis excluding
women who indicated a prior use in NHANES III was
generated. The deletion of former users from the non-
current use group did not appreciably change the
reported odds ratios (OR = 0.57; 95% CI: 0.38 to 0.95).
In addition, the absence of significant findings may
be due to the different methods used to assess perio-
dontal disease. Although it appears that there was a
decline in the prevalence of periodontitis between the
time that the NHANES I and NHANES III surveys were
performed (13.1% versus 10.7%), these discrepan-
cies may be attributed to differences in the clinical
methods of disease assessment. In NHANES I, the
assumptions related to periodontal disease progres-
sion and the use of the subjective PI may have
accounted for an inflated estimate of periodontitis
relative to the NHANES III findings. Likewise, in the
NHANES III data collection, split-mouth examinations
may have similarly underestimated the prevalence of
disease.44
Although other analyses have suggested no change
in gingivitis in the United States over recent years,45 our
study identified an increase of 10% in the prevalence
of gingivitis between NHANES I and NHANES III among
premenopausal women. It is quite possible that the use
of the PI, which gives greater weight to advanced dis-
ease, may have actually underreported gingivitis. There-
fore, the increase in gingivitis we observed is most
likely an artifact of the clinical methods employed. We
found that, while slightly higher, our estimates were
similar to those reported by Albandar and Kingman for
prevalence of gingival bleeding (gingivitis) for women
between the ages of 30 to 39 and 40 to 49 years in a
NHANES III analysis.45
In the analysis of the NHANES I population,
the association between periodontitis and OC use
depended on age. It appears that the protection derived
from current OC use may be particularly beneficial
with increasing age. How might age modify the effects
exerted by OC use? First, prior use of high-dose OCs
(>50 µg of estrogen) may have enhanced the devel-
opment of the attachment apparatus (e.g., bone mass,
periodontal ligament), such that when these same
women were at greatest risk for bone loss, it would
appear that OC use was protective. To our knowledge,
evidence for the association of exogenous estrogen
use for maintaining periodontal tissues among pre-
menopausal women is lacking, but estrogen supple-
mentation has been reported to be associated with
improved gingival health and reduced attachment loss
in post-menopausal women.46,47 However, age did not
appear to modify the association between current OC
use and prevalence of periodontitis in the older age
groups in the NHANES III survey. The small number
of current OC users among the older age groups may
have reduced our ability to detect an interaction
between age and OC use. An alternative possibility is
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that women who were former users may have dis-
continued pill use due to periodontal disease or other
problems associated with high-dose OC use, leaving
relatively healthier women. Thus, when compared with
non-current users, the lower prevalence of periodon-
titis among older current OC users may be the result
of survivor bias. Perhaps most likely is that behaviors
associated with OC use are protective, and this rela-
tionship is best demonstrated in women who are at
greatest risk in our study for periodontal disease –
those who are older. The patterns in the data consis-
tent with this interpretation only reached statistical sig-
nificance in the middle age range where sufficient
numbers of women at risk for periodontal disease were
also taking OCs.
Our findings that OC use may be protective for users
are of considerable interest. OC use may represent a
proxy for health or lifestyle behaviors that may be
associated with higher levels of income and better
periodontal health. Studies have suggested that women
who use OCs or hormone replacement therapy (HRT)
may differ from women who do not in terms of more
favorable lifestyles, higher education and income levels,
and health awareness.48-50
If the women in our study who used OCs had lower
overall risk profiles for periodontal diseases; i.e., were
healthier, had better oral health behaviors, and had
greater access to and use of dental care than non-
users, healthy user bias might explain some of the
reduced risk of periodontal disease we observed in
OC users. Unfortunately, direct measures of individ-
ual oral hygiene behavior were not made in the
NHANES III survey. Using date of last dental visit as
a proxy for oral hygiene status, more of the current
OC users than non-current users reported visiting a
dentist within the last 2 years. However, those who
were current OC users were also more likely to have
smoked (NHANES I) and consumed alcohol, sug-
gesting an increased risk of periodontitis (data not
shown). Yet the possibility remains that the putative
protective effect of OC use on periodontal diseases
that we observed in this study may be spurious and
a consequence of healthier lifestyles resulting from a
healthy woman bias. The inherent risk of healthy user
bias in observational studies, even after adjusting for
a wide range of covariates, was most recently
demonstrated when the surprising results of the
Women’s Health Initiative (WHI) Postmenopausal Hor-
mone Therapy Trial were released and the estrogen
plus progestin component of the study was prema-
turely halted. The risk of coronary heart disease,
breast cancer, and stroke increased in women assigned
treatment of estrogen plus progestin.51 Observational
studies of HRT had found consistent protection against
heart disease;52-54 this now appears due to strong
selection and healthy user biases.55,56 Women using
HRT in observational studies were healthier than those
not using HRT in an amount not fully correctable by
statistically controlling with available covariates, dis-
torting the true overall risk-benefit ratio of using HRT
for prevention of heart disease.
The results of our analysis did not substantiate the
previous theory that high-dose OC use is associated
with gingivitis or periodontitis. Furthermore, the pre-
sent findings suggest that there may be no detrimen-
tal association between modern low-dose OC use and
periodontal diseases for the majority of women who use
these products. While it is premature to make defini-
tive statements regarding a protective cause-and-effect
relationship between OC use and periodontal conditions
due to the cross-sectional nature of the data, these
findings suggest an important reexamination of the
perceived relationship between OC use and periodontal
diseases.
Further studies are needed to clarify the role of OCs
in periodontal disease and to determine the extent
to which self-selection bias and oral health behav-
iors affect the initiation or progression of periodontal
disease.
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